Overview
Brendan Killory is a Neurosurgery provider in Hartford, Connecticut. Dr. Killory is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Meningioma, Hydrocephalus, Absence Seizure, Awake Craniotomy, and Laminectomy.
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
85 Seymour St, Suite 1003, Hartford, CT 06106
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Yale University
Veronica Chiang is a Neurosurgery provider in New Haven, Connecticut. Dr. Chiang is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Metastatic Brain Tumor, Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Awake Craniotomy.
Yale University
Jennifer Moliterno-Gunel is a Neurosurgery provider in New Haven, Connecticut. Dr. Moliterno-Gunel is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Meningioma, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, Awake Craniotomy, and Gamma Knife Radiosurgery.
Umass Memorial Medical Group Inc
Mark Johnson is a Neurosurgery provider in Worcester, Massachusetts. Dr. Johnson is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Hydrocephalus, Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Subdural Hematoma, and Awake Craniotomy. Dr. Johnson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HydrocephalusDr. Killory isDistinguished. Learn about Hydrocephalus.
- MeningiomaDr. Killory isDistinguished. Learn about Meningioma.
- Advanced
- Absence SeizureDr. Killory isAdvanced. Learn about Absence Seizure.
- ApoplexyDr. Killory isAdvanced. Learn about Apoplexy.
- Arterial Calcification of InfancyDr. Killory isAdvanced. Learn about Arterial Calcification of Infancy.
- Arteriovenous MalformationDr. Killory isAdvanced. Learn about Arteriovenous Malformation.
- AstrocytomaDr. Killory isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Experienced
- Ankylosing Vertebral Hyperostosis with Tylosis
- Arachnoid CystsDr. Killory isExperienced. Learn about Arachnoid Cysts.
- Binder's SyndromeDr. Killory isExperienced. Learn about Binder's Syndrome.
- Brain AbscessDr. Killory isExperienced. Learn about Brain Abscess.
- Cerebellum Agenesis HydrocephalyDr. Killory isExperienced. Learn about Cerebellum Agenesis Hydrocephaly.
- Cerebral Ventricle CancerDr. Killory isExperienced. Learn about Cerebral Ventricle Cancer.